A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda
File(s)elife-20492-v3.pdf (1.11 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Evolutionary theory hypothesizes that intermediate virulence maximizes pathogen
fitness as a result of a trade-off between virulence and transmission, but empirical evidence
remains scarce. We bridge this gap using data from a large and long-standing HIV-1 prospective
cohort, in Uganda. We use an epidemiological-evolutionary model parameterised with this data to
derive evolutionary predictions based on analysis and detailed individual-based simulations. We
robustly predict stabilising selection towards a low level of virulence, and rapid attenuation of the
virus. Accordingly, set-point viral load, the most common measure of virulence, has declined in the
last 20 years. Our model also predicts that subtype A is slowly outcompeting subtype D, with both
subtypes becoming less virulent, as observed in the data. Reduction of set-point viral loads should
have resulted in a 20% reduction in incidence, and a three years extension of untreated
asymptomatic infection, increasing opportunities for timely treatment of infected individuals.
fitness as a result of a trade-off between virulence and transmission, but empirical evidence
remains scarce. We bridge this gap using data from a large and long-standing HIV-1 prospective
cohort, in Uganda. We use an epidemiological-evolutionary model parameterised with this data to
derive evolutionary predictions based on analysis and detailed individual-based simulations. We
robustly predict stabilising selection towards a low level of virulence, and rapid attenuation of the
virus. Accordingly, set-point viral load, the most common measure of virulence, has declined in the
last 20 years. Our model also predicts that subtype A is slowly outcompeting subtype D, with both
subtypes becoming less virulent, as observed in the data. Reduction of set-point viral loads should
have resulted in a 20% reduction in incidence, and a three years extension of untreated
asymptomatic infection, increasing opportunities for timely treatment of infected individuals.
Date Issued
2016-11-05
Date Acceptance
2016-11-01
Citation
eLife, 2016, 5
ISSN
2050-084X
Publisher
eLife Sciences Publications
Journal / Book Title
eLife
Volume
5
Copyright Statement
© 2016 Blanquart et al. This
article is distributed under the
terms of the Creative Commons
Attribution License (https://creativecommons.org/licenses/by/4.0/), which
permits unrestricted use and
redistribution provided that the
original author and source are
credited.
article is distributed under the
terms of the Creative Commons
Attribution License (https://creativecommons.org/licenses/by/4.0/), which
permits unrestricted use and
redistribution provided that the
original author and source are
credited.
Sponsor
Commission of the European Communities
Commission of the European Communities
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000388683400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
339251
657768
Subjects
Science & Technology
Life Sciences & Biomedicine
Biology
Life Sciences & Biomedicine - Other Topics
GENITAL ULCER DISEASE
SIMPLEX-VIRUS TYPE-2
VIRAL LOAD
PROGNOSTIC MARKERS
PROSPECTIVE COHORT
SET-POINT
PROGRESSION
POPULATION
INFECTION
RAKAI
adaptation
epidemiology
evolutionary biology
genomics
global health
quantitative genetics
selection
transmission-virulence trade-off
viral evolution
virus
Publication Status
Published
Article Number
ARTN e20492